Metminco Regulatory News (MNC)

Metminco Limited ("Metminco" or the "Company") (ASX: MNC; AIM: MNC) provides the following results from the Company Annual General Meeting ("Meeting") held on 28th May 2018. The Company advises that, members unanimously approved all resolutions set out in the Notice of Meeting on a show of hands at the Annual General Meeting held on 28 May 2018.

In accordance with ASX Listing Rule 3.13.2 and Section 251AA of the Corporations Law, set out below are the total number of proxy votes validly received which were exercisable in respect of each resolution considered at the Meeting and the manner in which those appointments specified that the proxies vote.

The Company provides the following additional disclosure relating to the appointment of Mr Glenister Lamont as director of Metminco, effective 28 May 2018:

Mr. Glenister Lamont, aged 61, currently holds or has held the following directorships and partnerships over the last five years:

Mr. Lamont has the following interests in securities of Metminco at the date of this announcement:

· 1,875,000 fully paid ordinary shares representing an interest of 0.21%

· 625,000 options at with an exercise price of A$0.011 and expiry date 1 June 2020

· 14,400,000 options approved at the Meeting subject to the following conditions and on the following terms:

o Tranche 1: 4,800,000 options vesting on Metminco achieving a 30 day Volume Weighted Average Price ("VWAP") of A$0.012 before an expiry date of 31 December 2018 and with an exercise price of A$0.012 per option;

o Tranche 2: 4,800,000 options vesting on Metminco achieving a 30 day VWAP of A$0.016 cents before an expiry date of 31 December 2019 and with an exercise price of A$0.016 per option; and

o Tranche 3: 4,800,000 options vesting on Metminco achieving a 30 day VWAP of A$0.024 before an expiry date of 31 December 2020 and with an exercise price of A$0.024 per option.

Except as disclosed in this announcement, neither the Company nor Mr. Lamont are aware of any further disclosures that are required in respect of the appointment of Mr. Glenister Lamont under Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

Mr Kevin Wilson has the following interests in securities at the date of this announcement.

· 2,551,312 fully paid ordinary shares representing an interest of 0.28%;

· 850,436 options at with an exercise price of A$0.011 and expiry date 1 June 2020;

· 4,166,667 Underwriter options, from resolution 6 of the AGM, with an exercise price of A$0.011 and expiry date 1 June 2020; and

· 58,000,000 Performance Rights approved at the Meeting with the following conditions:

·

o Tranche 1 - 11,600,000 Performance Rights vesting on Metminco achieving a 30 day VWAP of A$0.012 before December 31, 2018;

o Tranche 2 - 11,600,000 Performance Rights vesting on Metminco achieving a 30 day VWAP of A$0.016 before December 31, 2019;

o Tranche 3 - 11,600,000 Performance Rights vesting on delivery of a Resource of at least 1 million ounces gold at Tesorito before December 31, 2019;

o Tranche 4 - 11,600,000 Performance Rights vesting on Metminco achieving a 30 day VWAP of A$0.024 before December 31, 2020; and

o Tranche 5 - 11,600,000 Performance Rights vesting on delivery of a Resource of at least 1 million ounces gold at Chuscal before December 31, 2020.

Dr. Roger Higgins has the following interests directly or indirectly in securities of Metminco at the date of this announcement:

· 1,516,678 fully paid ordinary shares representing an interest of 0.17%;

· 417,637 options at with an exercise price of A$0.011 and expiry date 1 June 2020; and

· 14,400,000 options approved at the Meeting subject to the following conditions and on the following terms:

o Tranche 1: 4,800,000 options vesting on Metminco achieving a 30 day VWAP of A$0.012 before an expiry date of 31 December 2018 and with an exercise price of A$0.012 per option;

o Tranche 2: 4,800,000 options vesting on Metminco achieving a 30 day VWAP of A$0.016 cents before an expiry date of 31 December 2019 and with an exercise price of A$0.016 per option; and

o Tranche 3: 4,800,000 options vesting on Metminco achieving a 30 day VWAP of A$0.024 before an expiry date of 31 December 2020 and with an exercise price of A$0.024 per option.

The Company also advises that Mr. Francisco Vergara-Irarrazaval has stepped down from the Company's board, effective 28 May 2018, as he did not stand for re-election at the Meeting as previously advised. The Company thanks Mr. Vergara-Irarrazaval for his contributions.

Yours faithfully

Geoffrey Widmer

Joint Company Secretary